Document Detail

Antiphospholipid syndrome and pregnancy loss.
MedLine Citation:
PMID:  9829058     Owner:  NLM     Status:  MEDLINE    
Antiphospholipid antibodies (aPL) are associated with recurrent miscarriage. Pregnancies that survive the first trimester risk developing pre-eclampsia, intrauterine growth retardation and fetal distress during labour. Pregnancy loss is initially caused by defective embryonic implantation and later by thrombosis of the placental vasculature. In women with aPL, thromboprophylaxis during pregnancy improves the live birth rate.
R Rai; L Regan
Related Documents :
9176448 - Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization p...
9256308 - Obstetric outcome in antiphospholipid syndrome.
14587888 - Effect of sairei-to combined with aspirin and prednisolone on four recurrent reproducti...
1498338 - Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic...
15955268 - Management of genital herpes during pregnancy: the french experience.
24608578 - Brain ultrasound features in multiple births due to spontaneous conception compared wit...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Hospital medicine (London, England : 1998)     Volume:  59     ISSN:  1462-3935     ISO Abbreviation:  Hosp Med     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-12-03     Completed Date:  1998-12-03     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9803882     Medline TA:  Hosp Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  637-9     Citation Subset:  IM    
Department of Obstetrics and Gynaecology, Hillingdon Hospital, Uxbridge.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortion, Habitual / etiology*,  prevention & control
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Anticoagulants / therapeutic use
Antiphospholipid Syndrome / complications*,  diagnosis
Aspirin / therapeutic use
Diabetes Mellitus, Type 1 / complications
Heparin / therapeutic use
Pregnancy in Diabetics / complications
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Anticoagulants; 50-78-2/Aspirin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prenatal screening for Down syndrome.
Next Document:  Somatuline LA: a new treatment for acromegaly.